Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Explore year-end ETF Tax-Loss Harvesting ideas to harvest losses before year-end, diversify replacements, and sharpen tax efficiency.
25,086 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Lam Research has quietly outpaced rivals in AI tooling, delivering triple-digit gains as 2026 guidance stays upbeat. ...
Aramco’s chief executive warned that the oil market won’t return normal this year if the Iran conflict isn’t resolved...
IMDX kicked off 2026 with a solid Q1 showing, delivering revenue growth and improving margins while guiding higher fu...
Marvell Technology’s stock seesaws as AI demand accelerates its growth outlook, even as investors weigh cyclical chip...
This in-depth analysis examines signet (sig) 2027 earnings, focusing on Q1 2027 results, strategic levers, and what i...
Nvidia stock pulled back from late-May highs, creating a potential dip-buy opportunity as AI demand shows no clear sl...
Analysts on Wall Street continue lifting price targets for AMD as AI-enabled datacenters drive revenue growth and exp...
A senior tech market analyst argues that AI-driven data center investments are already generating value through pre-s...
Looking to secure the best mortgage rate in 2026? This practical guide breaks down the steps that save you money: sha...
Walmart isn't biggest company anymore, but its growth story isn t over. A new catalyst—driving e commerce, membership...
Investors are watching limoneira (lmnr) 2026 earnings for clues on citrus demand, real estate activity, and cost mana...